In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts. If you want to see more such stocks on the list, go directly to Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets.
On February 7, financial markets saw modest activity as investors awaited insights into interest rate policies from Federal Reserve representatives and analyzed China’s initiatives to stabilize its market. While Europe’s Stoxx 600 index slightly increased, US equity futures showed minimal fluctuations. Bond markets remained stable, with US government bonds holding steady before a notable $42 billion auction of 10-year Treasuries scheduled for Wednesday. Meanwhile, Asian equities demonstrated resilience, with a key index hitting its highest level in over a month. The cautious sentiment prevailed amid expectations of upcoming remarks from Federal Reserve officials, which could provide clues about the future trajectory of interest rates. Investors also closely monitored developments in China’s market, where volatility persisted despite efforts to shore up investor confidence. While Hong Kong stocks relinquished gains, mainland China shares experienced notable swings, reflecting the ongoing uncertainties in global markets. Although concerns about property markets loomed, particularly in China, market participants noted that the current situation did not mirror the severity of the Global Financial Crisis (GFC). Amid these dynamics, market participants remained vigilant, assessing the potential implications of central bank actions and geopolitical events on asset prices and investment strategies.
The uncertainty surrounding the timing of potential interest rate cuts by the Federal Reserve is causing ripples in the fixed income market, introducing heightened risk for investors who were banking on the momentum that propelled bond prices upward towards the end of 2023 to persist into this year. A surge in demand for Treasuries late last year was driven by expectations of rate cuts as early as the first quarter of 2024, which saw government bond prices rebound significantly from their lows over the past 16 years. However, recent developments, including robust U.S. job figures and a cautious stance from the Fed, have prompted a reassessment of these expectations, reported Reuters. The Fed’s warning that an overly hasty rate cut could fuel inflationary pressures in an already strong economy has led to a spike in yields on the benchmark 10-year Treasury in recent days, now standing 20 basis points higher than December’s lows. While investors still anticipate multiple rate cuts this year, they are less certain about the timing and magnitude of these cuts, given the evolving economic landscape. Robert Tipp, Chief Investment Strategist at PGIM Fixed Income, suggests that 10-year yields could approach last year’s highs of around 5% from their current level of approximately 4.1%. Futures tied to the Fed’s policy rate reflect a diminished probability of a rate cut in March, with expectations shifting towards a potential cut in May. Meanwhile, investors are pricing in a total of 122 basis points in cuts for 2024, down from around 150 in mid-January. Some market participants, such as John Madziyire from Vanguard, are adjusting their investment strategies in response to these developments, with a more cautious approach towards long-duration bonds. Spencer Hakimian of Tolou Capital Management has been reducing exposure to long-term Treasuries and favoring shorter-term ones, anticipating prolonged periods of elevated rates. Concerns over anticipated high issuance of new U.S. government bonds this year are also weighing on investor sentiment, with expectations that yields may need to rise to attract buyers. Despite the rise in yields, stocks have remained resilient, with the S&P 500 hovering near record highs, suggesting diverging sentiments between the bond and equity markets.
On the stock market front, analysts are bullish on stocks such as Honeywell International Inc. (NASDAQ:HON) and The Estée Lauder Companies Inc. (NYSE:EL) among many others. Check out the complete article to see the details of these upward revisions in price targets.
10. Costco Wholesale Corporation (NASDAQ:COST)
Upside Potential: 6%
On February 6, within the retail sector, there was notable activity surrounding the stock of Costco Wholesale Corporation (NASDAQ:COST), a leading American multinational corporation renowned for its membership-only warehouse clubs. Telsey Advisory Group made significant adjustments to their analysis of Costco Wholesale Corporation (NASDAQ:COST) stock. They raised the target price from $700.00 to $750.00 per share and reaffirmed their “outperform” rating on the stock. This update came as Costco Wholesale Corporation (NASDAQ:COST) market price closed at $710.79, indicating an upside potential of approximately 6% based on Telsey Advisory Group’s revised target price. Telsey Advisory Group’s decision to increase the target price and maintain a positive outlook on Costco Wholesale Corporation (NASDAQ:COST) highlights their confidence in the company’s future performance and growth prospects.
Madison Sustainable Equity Fund stated the following regarding Costco Wholesale Corporation (NASDAQ:COST) in its fourth quarter 2023 investor letter:
“Costco Wholesale Corporation (NASDAQ:COST) reported solid holiday results and announced a special dividend of $15 per share. Earnings were better than expected driven by better gross margin. Same store sales were 3.9% with solid traffic. Costco also noted better discretionary trends and solid seasonal sales.”
09. Uber Technologies, Inc. (NYSE:UBER)
Upside Potential: 12%
On February 6, in the technology and transportation sector, notable activity surrounded Uber Technologies, Inc. (NYSE:UBER), a prominent multinational ride-hailing and food delivery company. KeyBanc made significant adjustments to their evaluation of Uber Technologies, Inc. (NYSE:UBER) stock. They raised the price target from $70 to $79 per share while reiterating their Overweight rating for the stock. This update coincided with Uber Technologies, Inc. (NYSE:UBER) market price closing at $70.46, indicating a potential upside of approximately 12% based on KeyBanc’s revised price target. KeyBanc’s decision to increase the price target and maintain a positive outlook on Uber Technologies, Inc. (NYSE:UBER) underscores their confidence in the company’s future performance and growth potential.
RiverPark Advisors made the following comment about Uber Technologies, Inc. (NYSE:UBER) in its Q3 2023 investor letter:
“Uber Technologies, Inc. (NYSE:UBER): UBER was the top contributor in the quarter following a better-than-expected 2Q23 earnings report and 3Q23 guidance. Gross bookings of $33.6 billion were up 16% year over year. Mobility gross bookings of $17 billion grew 25% over last year driven by a combination of product innovation and driver availability. Delivery gross bookings of $16 billion were up 12% from last year. 2Q Adjusted EBITDA of $916 million, up $552 million year over year, significantly beat Street estimates of $845 million and the company generated $1.1 billion of free cash flow. Management guided to continuing growth in 3Q Gross Bookings (17%-20% growth) and Adjusted EBITDA (of $975-1,025 million).
UBER remains the undisputed global leader in ride sharing, with a greater than 50% share in every major region in which it operates. The company is also a leader in food delivery, where it is number one or two in the more than 25 countries in which it operates. Moreover, after a history of losses, the company is now profitable, delivering expanding margins and substantial free cash flow. We view UBER as more than just ride sharing and food delivery, but also as a global mobility platform with the ability to sell to its 130 million users (by comparison, Amazon Prime has 200 million members) and penetrate new markets of on-demand services, such as package and grocery delivery, travel, and worker staffing for shift work. Given its $4.3 billion of unrestricted cash and $4.4 billion of investments, the company’s enterprise value of $95 billion equates to just over 20x next year’s estimated free cash flow.”
08. AbbVie Inc. (NYSE:ABBV)
Upside Potential: 13%
On February 6, TruistSecurities issued an update on AbbVie Inc. (NYSE:ABBV), a prominent player in the pharmaceutical and healthcare sector. This revision came with significant implications for investors, as TruistSecurities analyst Robyn Karnauskas reiterated a Buy rating for AbbVie Inc. (NYSE:ABBV) while simultaneously raising the price target from $180 to $195 per share. This adjustment arrived amidst AbbVie Inc. (NYSE:ABBV) stock closing at $173.27 on the same day, indicating a potential upside of approximately 13% based on TruistSecurities’ revised price target. By increasing the price target, TruistSecurities signals confidence in AbbVie Inc. (NYSE:ABBV) ability to deliver shareholder value and sustain growth in the foreseeable future. TruistSecurities’ bullish stance on AbbVie Inc. (NYSE:ABBV) suggests optimism regarding the company’s strategic initiatives, product pipeline, and overall market dynamics. As market participants digest this updated analysis, it may influence trading activity and investment decisions related to AbbVie Inc. (NYSE:ABBV) stock in the days and weeks ahead.
Carillon Eagle Mid Cap Growth Fund made the following comment about AbbVie Inc. (NYSE:ABBV) in its Q3 2023 investor letter:
“AbbVie Inc. (NYSE:ABBV) reported strong, broad-based second-quarter performance that exceeded analysts’ expectations. The company’s raised guidance was a nice recovery after its mildly disappointing first-quarter report.”
07. DoorDash, Inc. (NASDAQ:DASH)
Upside Potential: 16%
On February 6, JMP Securities provided an update on DoorDash, Inc. (NASDAQ:DASH), a prominent player in the food delivery industry. This development carried significant implications for investors, as JMP Securities analyst Andrew Boone increased the price target for DoorDash, Inc. (NASDAQ:DASH) to $130.00 per share, up from the previous target of $113.00. This adjustment came as DoorDash’s stock closed at $112.34 on the same day, indicating a potential upside of approximately 16% based on JMP Securities’ revised price target. By raising the price target while maintaining a Market Outperform rating, JMP Securities expresses confidence in DoorDash, Inc. (NASDAQ:DASH) ability to capitalize on opportunities and deliver value to investors. JMP Securities’ optimistic outlook on DoorDash, Inc. (NASDAQ:DASH) suggests belief in the company’s growth potential and ability to navigate challenges in the evolving market landscape. As investors digest this updated analysis, it may influence trading activity and investment decisions related to DoorDash, Inc. (NASDAQ:DASH) stock in the coming days and weeks.
06. Eli Lilly and Company (NYSE:LLY)
Upside Potential: 17%
On February 6, Wells Fargo & Company adjusted its outlook for Eli Lilly and Company (NYSE:LLY), a prominent player in the pharmaceutical industry. This update carried significance for investors as it indicated potential opportunities within the pharmaceutical sector. Specifically, Wells Fargo analysts increased Eli Lilly and Company (NYSE:LLY) price target from $700.00 to $825.00 per share, while affirming an “overweight” rating for the stock. This adjustment came as Eli Lilly and Company (NYSE:LLY) stock closed at $705.01 on the same day, suggesting a promising upside potential of approximately 17% based on Wells Fargo’s revised price target. By maintaining an “overweight” rating alongside the increased price target, Wells Fargo expressed confidence in Eli Lilly’s ability to generate shareholder value and outperform market expectations. The upward revision of Eli Lilly and Company (NYSE:LLY) price target suggests optimism regarding the company’s growth prospects and its ability to deliver sustained returns over the long term. Investors and industry observers closely monitor such assessments, as they provide valuable guidance amid evolving market conditions and regulatory developments within the pharmaceutical sector.
Baron Health Care Fund stated the following regarding Eli Lilly and Company (NYSE:LLY) in its fourth quarter 2023 investor letter:
“Stock selection was also positive in the sub-industry owing to strong gains from therapeutics-focused pharmaceutical giant Eli Lilly and Company (NYSE:LLY). Lilly’s stock continued to outperform driven by strong sales of blockbuster diabetes medicine Mounjaro and ongoing enthusiasm surrounding the company’s obesity and diabetes franchises, particularly after Novo Nordisk released its SELECT trial results showing a 20% relative risk reduction in overweight patients with cardiovascular disease and no prior history of diabetes.
Eli Lilly and Company is a global pharmaceutical company that discovers, develops, manufactures, and sells medicines in the categories of diabetes, oncology, neuroscience, and immunology, among other areas. Stock performance was strong due to strong third quarter sales of blockbuster diabetes medicine Mounjaro and ongoing enthusiasm surrounding the company’s obesity and diabetes franchises. We continue to think Lilly is well positioned to grow revenue and earnings at attractive rates through the end of the decade and beyond.
We own Eli Lilly and Company, which we believe will remain a leader in the GLP-1 medicine class with Mounjaro, Zepbound, and the company’s deep pipeline of next generation GLP-1 medicines.”
Click to continue reading and see Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets.
Suggested articles:
- 10 Best Gold Royalty and Small-Cap Gold Stocks to Buy
- 11 Best American Defense Stocks To Buy According to Analysts
- Jim Cramer is Bearish on These 12 Stocks
Disclosure. None. Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets is originally published on Insider Monkey.
